Arbutus Biopharma Aktie
WKN DE: A14XMD / ISIN: CA03879J1003
27.03.2025 12:49:24
|
Arbutus Biopharma Corp. Full Year Loss Narrows
(RTTNews) - Arbutus Biopharma Corp. (ABUS) reported Loss for full year of -$69.92 million
The company's earnings totaled -$69.92 million, or -$0.38 per share. This compares with -$72.85 million, or -$0.44 per share, last year.
The company's revenue for the period fell 66.0% to $6.17 million from $18.14 million last year.
Arbutus Biopharma Corp. earnings at a glance (GAAP) :
-Earnings: -$69.92 Mln. vs. -$72.85 Mln. last year. -EPS: -$0.38 vs. -$0.44 last year. -Revenue: $6.17 Mln vs. $18.14 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Arbutus Biopharma Corpmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Arbutus Biopharma Corpmehr Analysen
Aktien in diesem Artikel
Arbutus Biopharma Corp | 2,98 | -1,19% |
|